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Proportion of Lifetime UV Dose Received by Age 18, What Stern
et al Actually Said in 1986
To the Editor:
I read with interest Thieden et al’s (2004) study that as-
sessed UV exposure among children, teenagers, and adults
in Copenhagen. As have many ‘‘campaigns’’ and most of
the more than 200 publications that cite our work that I have
read, the authors appear to have failed to understand our
findings and misquote our work (Stern et al, 1986).
We developed a mathematical model of the relation of
UV exposure, age, and other factors to non-melanoma skin
cancer (NMSC) risk. We used this model to estimate the risk
reduction that could be achieved with the regular use of a
high SPF sunscreen for NMSC. Our model predicted that
consistent use of high SPF sunscreen to age 18 would re-
duce the lifetime risk of NMSC by 78% (base case analysis).
In our base case analysis, we assumed that children living in
the northern United States spend three times as much time
in the sun as adults annually. This assumption is consistent
with slightly less than half of the total lifetime sun exposure
occurring by age 18.
Because we understood that our base case assumption
about sun exposure was based on scant data and the ratio
of childhood to adult sun exposure would affect the pre-
dicted effect of childhood sun protection on lifetime skin
cancer risk reduction, our model included an independent
variable to account for the variability in the ratio of annual
child to adult sun exposure, which we termed the sun af-
finity ratio (SAR) (Table I) (Fig 1).
Our sensitivity analyses examined the impact of various
assumptions about sun exposure patterns over a lifetime
(i.e., varying SAR) on the primary endpoint: lifetime NMSC
risk reduction with effective UV protection up to age 18. One
full journal page of our paper as well as a figure and a table
(reproduced here from Stern, 1986) detailed these concerns
and the range of assumptions about sun exposure habits
over a lifetime that we utilized in our sensitivity analysis. The
extreme low and high assumptions of SAR that we utilized
in our sensitivity analysis are consistent: 16% and 78% of total
lifetime UV exposure occurring up to age 18, respectively. The
extreme high case would describe a youthful sun worshiper
who becomes a compulsive sun avoider after age 18.
The greater importance of sun exposure early in life than
in adult years for NMSC lifetime risk, particularly basal can-
cer risk, is supported by epidemiologic studies performed
subsequent to our study (Gallagher, 1995; Corona et al,
2001). Our model, which assumed a multistage model of
carcinogenesis, accounted for the latency between expo-
sure to a carcinogen and the actual development of the
cancer. Such a latency period is observed for most cancers.
As a result, the same UV exposure many years in the past
(i.e., as a youth) is likely to have been a greater contributor
to the development of a skin cancer that develops in an
adult than a comparable quantity of recent exposure. Be-
cause of latency between exposure and cancer, when we
assumed annual sun exposure is the same throughout life
(SAR¼ 1% and 21% of lifetime exposure occurring to age
18), the reduction in lifetime skin cancer risk predicted with
high levels of sun protection to age 18 decreased to 62%
from our base case prediction of 78% risk reduction (with
SAR¼3% and 45% of exposure occurring up to age 18).
Of course, the pattern of an individual’s sun exposure
over a lifetime is likely to be an even more complex one than
described by the SAR. We are pleased that our early work
has stimulated studies such as Thieden’s, which attempts
to quantify sun exposure patterns. But, an assessment of
the robustness of Thieden’s findings and their relevance to
our base case assumptions should consider changes in
habits over the last two decades as well as the generaliz-
ability and precision of Thieden’s findings.
Since the 1980s, sun exposure habits may have
changed. Perhaps the message that we and others subse-
quently emphasized, decreasing childhood sun exposure is
particularly important for NMSC risk reduction, has actually
reduced sun-seeking behavior in children more than adults
(i.e., decreased the SAR).
Data from Denmark may not reflect US conditions. My
lucky adult Scandinavian friends seem to have nearly as
much opportunity for sun exposure as their children
(SAR¼ 1) and along with my children have at least three
times the summer vacation I have (i.e., SAR¼ 3). These dif-
ferences from my small and admittedly biased sample
highlight the cultural and social determinants of SAR and
the importance of unbiased sampling if estimates that ac-
curately reflect a large population too are achieved. Thi-
eden’s sample of Danish health care workers and golfers
seems unlikely to be an ideal one to assess sun exposure
patterns in the general population.
Thieden does not detail the power or precision of her
estimates. But, the groups she studied are quite small (less
than five subjects per year of age for those less than 20 and
less than two subjects per year of age over age 20). Even if
the authors were fortunate enough to have recruited a sam-
Table I. Sun afﬁnity ratios (SAR)
used in the analysis of skin cancer riska
Adult sun afﬁnity
Child sun affinity Lowb Average Highc
Lowd 6 2 2/3
Average 9 3 1
Highe 12 4 1 12
aAn average child is assumed to have three times the annual sun ex-
posure of an average adult.
bOne-third times average.
cThree times average; nine times low.
dTwo-thirds times average.
eOne and one-third times average; two times below.
Reference: Stern (1986).Abbreviations: NMSC, non-melanoma skin cancer; SAR, sun af-
finity ratio
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ple that is truly representative of the Danish population, Thi-
eden’s findings are likely to be more applicable to 21st-cen-
tury Denmark, a quite northern country (latitude 551) blessed
with far more generous vacations than those who worked in
not quite tropical Boston (latitude 421) in the 1980s.
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Vitamin D Induces the Antimicrobial Protein hCAP18
in Human Skin
To the Editor:
Cathelicidins are a class of mammalian antimicrobial pep-
tides expressed in leukocytes and at epithelial surfaces
(Zanetti, 2004). Human cathelicidin antimicrobial protein
hCAP18 is encoded by CAMP (Ensembl Gene ID ENS
G00000164047) on chromosomal location 3p21 and is the
sole cathelicidin protein in humans. Recent studies have
shown that cathelicidins, in addition to being antimicrobial,
are multifunctional proteins with receptor-mediated effects
on eukaryotic cells and activity in chemotaxis, angiogene-
sis, and wound healing (Zaiou et al, 2003; Zanetti, 2004). In
the skin, there is low constitutive expression of hCAP18 in
the basal layer of keratinocytes but rapid upregulation upon
inflammation and injury (Frohm Nilsson et al, 1999; Dors-
chner et al, 2001; Heilborn et al, 2003).
Molecular mechanisms controlling the expression of
CAMP are still poorly understood. We have investigated
whether its expression could be influenced by agents that
affect the proliferation and differentiation of skin keratin-
ocytes. Human neonatal epidermal keratinocytes (Cascade
Biologics, Portland, Oregon) were cultured in EpiLife serum-
free keratinocyte growth medium (Cascade Biologics) con-
taining growth supplements and a calcium concentration of
0.06 mM. At 60% confluency, the agents assayed were
added to the medium and cells were harvested after 24 h.
RNA was extracted and reverse transcribed by standard
methods, and the expression was quantified by Real-Time
RT-PCR on an ABI Prism 7700 (Applied Biosystems, Foster
City, California) using 5 ng of cDNA according to standard
protocols. Sequences were 50-GTCACCAGAGGATTGTGA-
CTTCAA-30 and 50-TTGAGGGTCACTGTCCCCATA-30 for
the primers, and 6-FAM–50-CCGCTTCACCAGCCCGTC-
CTT-30–BHQ1 for the fluorigenic probe.
An upregulation of CAMP of about one order of magni-
tude was achieved by treatment with 100 nM MC903/ca-
lcipotriol, a vitamin D analog applied for psoriasis treatment
(Kragballe, 1995). Calcium is known to regulate major func-
tions of the epidermis including terminal differentiation. Pre-
treatment of cells by 1.5 mM calcium for 48 h increased the
expression by about 1.5-fold, and was synergistic to the
effects of MC903 (Fig 1a). Based on these findings, we as-
sayed the effect of vitamin D and its metabolites (all from
Fluka, Buchs, Switzerland). Both biologically active forms
of vitamin D3, i.e., 1,25(OH)2D3 and 25(OH)D3, stimulated
CAMP expression at the same magnitude as MC903. The
corresponding vitamin D2 analogs were slightly less effi-
cient. All compounds were active down to levels of 10 nM
(shown for 1,25(OH)2D3). The precursor of vitamin D bio-
synthesis, 7-dehydrocholesterol (7-DHC), was ineffective.
Western blot analysis confirmed that the elevated transcrip-
tion was reflected on the protein level (Fig 1b).
An in silico analysis revealed two putative vitamin D re-
sponsive elements (VDRE) of the DR3 type, and one puta-
tive heterodimer site of the DR5 type, within 1 kb upstream
of the transcription start (Table I). This region was subcloned
Figure 1
Age pattern of ultraviolet-B exposure. SPF indicates sun protective
factor; SAR, sun affinity ratio; and d, dose affiliations
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